Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06107933 · ClinicalTrials.gov registry record
Developmental Impacts of Microplastics Exposure in Early Life
A clinical trial of Breastfeeding and Infant Development, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06107933: Recruiting study of Breastfeeding and Infant Development, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT06107933 is a study of Breastfeeding and Infant Development that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 40 participants, below the 596-participant average among 36 other Breastfeeding trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06107933, a study of Breastfeeding and Infant Development, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to characterize and evaluate micro- and nano-plastic (MNP) exposures among mothers and infants in mother-infant dyads 1 or 3 months postpartum living in Baltimore, Maryland. The main questions it aims to answer are: * What MNPs are present in breastmilk and maternal blood samples and in their infants stool sample? * Are there associations between amount of maternal MNPs in breast milk and mass of MNP particles in infant stool? * Which environmental and lifestyle factors are most predictive of maternal MNP burden? * Is infant exposure to MNPs associated with birth weight and postnatal growth trajectories? Participants will: * Complete several questionnaires assessing medical histories, lifestyle factors, environmental exposures, eating behaviors, etc. * Provide biological specimens including: maternal blood, stool, and breastmilk; infant stool * Clinical visit to have anthropometric measures documented including maternal height and weight, infant weight, length, and skin-fold thickness
Primary Outcome
MNPs are measured using pyrolysis GC-HRMS using a Frontier Multi-Shot Pyrolyzer with Auto-Shot Sampler interfaced to a Trace 1310 gas chromatography system and Thermo Scientific Q Exactive GC Orbitrap GC-MS/MS.
Conditions Studied
Interventions
- OTHER Observational only
Study Locations (1)
Maryland
- East Baltimore Pediatric Inpatient and Outpatient Clinical Research Unit - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2027-01-01 |
What NCT06107933 shows while recruiting
NCT06107933 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 596-participant average among 36 other Breastfeeding trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Breastfeeding appearing as the primary indexed condition, and to 1 intervention - of which Observational only is the first listed.
NCT06107933 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06107933 about?
NCT06107933 is a clinical study titled "Developmental Impacts of Microplastics Exposure in Early Life". The goal of this observational study is to characterize and evaluate micro- and nano-plastic (MNP) exposures among mothers and infants in mother-infant dyads 1 or 3 months postpartum living in Baltimore, Maryland. The main questions it aims to answer are: * What MNPs are present in breastmilk and m...
What is the current status of trial NCT06107933?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-10-01. Estimated completion is 2027-01-01.
What conditions does trial NCT06107933 study?
This clinical trial studies the following conditions: Breastfeeding, Infant Development, Environmental Exposure.
What interventions are being tested in trial NCT06107933?
The interventions under investigation include: Observational only (OTHER).
Who is sponsoring clinical trial NCT06107933?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06107933 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breastfeeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06107933's enrollment target sits among peer trials
40 29th of 36 higher than 4 of 36 other Breastfeeding trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breastfeeding trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
RECRUITING
-
Furthering Equity Through Infant Feeding EDucation and Support
RECRUITING · NA
-
Excretion of Rivaroxaban in Human Breast Milk
RECRUITING · Phase 1
-
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
RECRUITING
-
Support Via Online Social Networks to Promote Safe Infant Care Practices
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI